Stay updated on Isatuximab for High-Risk Smoldering Myeloma Clinical Trial

Sign up to get notified when there's something new on the Isatuximab for High-Risk Smoldering Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Isatuximab for High-Risk Smoldering Myeloma Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    A minor ClinicalTrials.gov page revision/version update changes the displayed “Revision: v3.5.x” label from v3.5.2 to v3.5.3 without altering the trial record’s substantive details.
    Difference
    0.1%
    Check dated 2026-04-25T18:55:26.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    A new 'Study Status' entry was added to the history, and the record was upgraded to Revision v3.5.2, while the older Revision v3.5.0 was removed.
    Difference
    0.3%
    Check dated 2026-04-18T13:46:46.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    37 days ago
    Change Detected
    Summary
    Revision: v3.5.0 was added and v3.4.3 was removed in the history. This looks like a system update with no changes to the study information visible on the page.
    Difference
    0.1%
    Check dated 2026-03-21T00:45:18.000Z thumbnail image
  5. Check
    51 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-06T18:43:02.000Z thumbnail image
  6. Check
    72 days ago
    Change Detected
    Summary
    Footer revision updated from v3.4.1 to v3.4.2; no substantive changes to content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-13T12:29:26.000Z thumbnail image
  7. Check
    80 days ago
    Change Detected
    Summary
    Revision: v3.4.1 was added and Revision: v3.4.0 was removed from the history display.
    Difference
    0.1%
    Check dated 2026-02-05T22:52:36.000Z thumbnail image

Stay in the know with updates to Isatuximab for High-Risk Smoldering Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Isatuximab for High-Risk Smoldering Myeloma Clinical Trial page.